Published in Eur J Pharmacol on September 01, 1989
Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol (2011) 1.84
TrkA gene ablation in basal forebrain results in dysfunction of the cholinergic circuitry. J Neurosci (2012) 0.99
GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J Comp Neurol (2013) 0.91
Motor deficits and altered striatal gene expression in aphakia (ak) mice. Brain Res (2007) 0.82
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem (1989) 2.75
Promoting responsible conduct in research through "survival skills" workshops: some mentoring is best done in a crowd. Sci Eng Ethics (2001) 2.01
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A (1996) 1.75
Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci (2001) 1.66
Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience (1988) 1.54
Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience (1995) 1.37
cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J Neurochem (2003) 1.21
Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res (1990) 1.20
Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell (2001) 1.20
Nuclear accumulation of fibroblast growth factor receptors in human glial cells--association with cell proliferation. Oncogene (1997) 1.19
Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. J Pharmacol Exp Ther (1977) 1.15
TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol (2009) 1.09
The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res (1997) 1.09
Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem (1995) 1.09
Amphetamine and operant behavior in rats: relationship between drug effect and control response rate. J Comp Physiol Psychol (1974) 1.08
Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience (2001) 1.07
Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J Neurochem (1994) 1.07
The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br J Pharmacol (1983) 1.06
Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol (1984) 1.06
Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene (1997) 1.05
Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. J Neurochem (1994) 1.05
Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem (1996) 1.04
Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem (1995) 1.02
Microinjections of anisomycin into the intermediate cerebellum during learning affect the acquisition of classically conditioned responses in the rabbit. Brain Res (1998) 1.02
Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol (1996) 1.02
Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res (1996) 1.01
Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metab Brain Dis (2009) 0.99
Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci (2001) 0.98
Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience (1997) 0.98
Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience (2000) 0.97
Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res (1984) 0.94
Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Neuroscience (1997) 0.94
Cruciform-extruding regulatory element controls cell-specific activity of the tyrosine hydroxylase gene promoter. Nucleic Acids Res (1998) 0.93
Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science (1972) 0.92
Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J Neurosci (1991) 0.92
Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience (1990) 0.92
In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J Neural Transm Gen Sect (1993) 0.92
Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci (1989) 0.89
Parkinson's disease: studies with an animal model. Life Sci (1984) 0.89
Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J Neurochem (1997) 0.89
Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Arch Neurol (1989) 0.89
Stress-induced neurological impairments in an animal model of parkinsonism. Ann Neurol (1985) 0.89
Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells. Proc Natl Acad Sci U S A (1996) 0.89
Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. Mol Biol Cell (1998) 0.88
Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science (1973) 0.88
Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology (2002) 0.87
Effect of chronic cold exposure on tyrosine hydroxylase mRNA in rat adrenal gland. Brain Res (1985) 0.87
Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. J Neurochem (1990) 0.87
Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J Neurosci (1987) 0.87
ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. J Neurosci Methods (2007) 0.87
Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem (2002) 0.87
Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. J Neurochem (1993) 0.87
Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther (1990) 0.86
Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J Neural Transm Suppl (1997) 0.86
Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience (2000) 0.86
Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress. J Pharmacol Exp Ther (1985) 0.85
Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Res (1978) 0.85
Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Exp Neurol (2005) 0.85
Recovery of hippocampal dentate granule cell responsiveness to entorhinal cortical input following norepinephrine depletion. Brain Res (1993) 0.85
Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain Res (1989) 0.85
High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. J Neurochem (1984) 0.84
Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res (1986) 0.84
High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J Pharmacol Exp Ther (1991) 0.84
Characterization of [3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience (1988) 0.84
Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Res (1990) 0.84
Bovine tyrosine hydroxylase gene-promoter regions involved in basal and angiotensin II-stimulated expression in nontransformed adrenal medullary cells. J Neurochem (1994) 0.84
Identification and distribution of Parkin in rat brain. Neuroreport (1999) 0.84
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. Prog Neuropsychopharmacol (1980) 0.84
α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia. Schizophr Res (2012) 0.83
Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. Stress (2008) 0.83
Hepatic tyrosine transaminase rhythm: interaction of environmental lighting, food consumption and dietary protein content. J Nutr (1969) 0.83
Incubation of tissue slices in the absence of Ca2+ and Mg2+ can cause nonspecific damage. J Neurochem (1991) 0.83
Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology (Berl) (2000) 0.83
The effects of L-dopa on in vitro dopamine release from striatum. Brain Res (1990) 0.82
Analysis of tyrosine hydroxylase gene transcription using an intron specific probe. J Neurosci Methods (2000) 0.82
Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol (1983) 0.82
Brain catecholamines and the central control of food intake. Int J Obes (1984) 0.82
Increased tyrosine phosphorylation and novel cis-acting element mediate activation of the fibroblast growth factor-2 (FGF-2) gene by nicotinic acetylcholine receptor. New mechanism for trans-synaptic regulation of cellular development and plasticity. Brain Res Mol Brain Res (1998) 0.82
Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols. Brain Res (1999) 0.82
Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Res (1988) 0.81
Basic fibroblast growth factor (bFGF) regulates tyrosine hydroxylase and proenkephalin mRNA levels in adrenal chromaffin cells. Brain Res (1993) 0.81
Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Res (1983) 0.81
Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull (1998) 0.81
Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Arch Neurol (1991) 0.81
Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine. J Pharmacol Exp Ther (1970) 0.81
The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons. Brain Res (1988) 0.81
Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem Pharmacol (1986) 0.81
Immunodetection of Parkin protein in vertebrate and invertebrate brains: a comparative study using specific antibodies. J Chem Neuroanat (2001) 0.81
A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid. Life Sci (1978) 0.80
Molecular adaptations in catecholamine biosynthesis induced by cold stress and sympathectomy. J Neurosci Res (1986) 0.80
Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia (1980) 0.80
High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine. Life Sci (1978) 0.80
Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Res (1983) 0.80
Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes. J Pharmacol Exp Ther (1979) 0.80
Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science (1980) 0.80